香雪制药
(300147)
| 流通市值：23.73亿 | | | 总市值：23.87亿 |
| 流通股本：6.57亿 | | | 总股本：6.61亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 130,958,958.84 | 127,449,530.34 | 142,992,750.49 | 166,503,309.05 |
| 应收票据及应收账款 | 803,781,630.63 | 776,817,057.94 | 733,768,034.52 | 681,650,181.65 |
| 其中：应收票据 | 151,280,334.78 | 144,466,532.74 | 131,155,721.51 | 81,663,333.6 |
| 应收账款 | 652,501,295.85 | 632,350,525.2 | 602,612,313.01 | 599,986,848.05 |
| 应收款项融资 | 2,341,264.91 | 7,895,748.32 | 8,037,702.25 | 20,051,572.16 |
| 预付款项 | 22,651,536.54 | 29,768,102.71 | 38,931,883.75 | 54,656,006.08 |
| 其他应收款合计 | 54,205,138.25 | 55,545,594.4 | 65,349,455.59 | 76,465,890.03 |
| 应收股利 | 22,436,980.32 | 22,436,980.32 | 22,436,980.32 | 22,436,980.32 |
| 存货 | 504,957,567.51 | 490,782,328.77 | 507,634,706.79 | 467,074,930.98 |
| 其他流动资产 | 78,550,874.86 | 80,124,591.09 | 87,903,714.93 | 88,183,213.3 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,888,651,236.71 | 1,657,477,988.88 | 1,700,580,341.88 | 1,693,187,412.38 |
| 非流动资产: | | | | |
| 长期股权投资 | 107,081,192.17 | 308,471,664.38 | 336,381,000.47 | 335,697,564.78 |
| 其他权益工具投资 | 88,984,401 | 88,984,401 | 88,984,401 | 88,984,401 |
| 其他非流动金融资产 | 45,948,605.86 | 47,333,134.73 | 47,338,726.32 | 47,347,807.23 |
| 固定资产 | 3,747,377,106.24 | 3,792,795,969.84 | 3,835,534,680.01 | 3,882,178,135.67 |
| 在建工程 | 1,635,297,863.94 | 1,634,010,321.3 | 1,631,684,465.11 | 1,616,820,457.77 |
| 生产性生物资产 | 537,995.76 | 675,001.33 | 628,345.31 | 579,353.15 |
| 使用权资产 | 23,388,368.85 | 24,268,677.96 | 25,376,482.24 | 26,484,286.51 |
| 无形资产 | 929,268,862.89 | 941,046,919.62 | 951,919,062.36 | 964,094,710.36 |
| 开发支出 | 422,591,041.72 | 415,851,378.78 | 409,338,116.85 | 402,926,139.43 |
| 商誉 | 199,720,237.13 | 199,720,237.13 | 199,720,237.13 | 199,720,237.13 |
| 长期待摊费用 | 37,381,324.96 | 37,858,118.43 | 37,149,845.88 | 37,724,484.79 |
| 递延所得税资产 | 26,572,498.57 | 28,500,858.36 | 26,367,156.96 | 26,305,850.74 |
| 其他非流动资产 | 34,098,192.82 | 34,386,607.75 | 29,477,794.43 | 30,949,698.04 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 7,298,247,691.91 | 7,553,903,290.61 | 7,619,900,314.07 | 7,659,813,126.6 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 9,186,898,928.62 | 9,211,381,279.49 | 9,320,480,655.95 | 9,353,000,538.98 |
| 流动负债: | | | | |
| 短期借款 | 1,510,373,221.13 | 1,506,178,501.25 | 1,978,190,652.97 | 1,926,082,937.94 |
| 应付票据及应付账款 | 903,189,707.86 | 882,112,046.59 | 860,802,539.36 | 841,313,237.86 |
| 其中：应付票据 | 9,189,335.61 | 10,725,859.21 | 12,207,988.76 | 17,945,631 |
| 应付账款 | 894,000,372.25 | 871,386,187.38 | 848,594,550.6 | 823,367,606.86 |
| 预收款项 | 0 | - | - | 798,165.14 |
| 合同负债 | 101,945,329.43 | 126,266,119.26 | 175,434,085.15 | 248,987,222.14 |
| 应付职工薪酬 | 42,480,980.84 | 39,023,081.4 | 36,468,393.01 | 34,279,253.4 |
| 应交税费 | 57,109,319.01 | 50,345,530.98 | 34,504,381.32 | 33,597,229.11 |
| 其他应付款合计 | 2,567,322,901.41 | 2,512,742,562.76 | 2,518,432,066.21 | 2,569,601,527.07 |
| 应付股利 | - | - | 7,666,840 | 15,666,840 |
| 一年内到期的非流动负债 | 118,131,371.32 | 156,217,269.7 | 78,922,444.29 | 79,974,137.6 |
| 其他流动负债 | 85,827,132.15 | 95,268,166.56 | 90,024,415.85 | 80,488,203.08 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 5,421,618,904.32 | 5,401,174,279.27 | 5,805,332,198.05 | 5,852,556,245.74 |
| 非流动负债: | | | | |
| 长期借款 | 815,388,470 | 780,436,970 | 426,680,976.5 | 426,930,976.5 |
| 租赁负债 | 12,928,147.81 | 23,133,167.97 | 22,339,307.64 | 24,919,116.15 |
| 长期应付款 | 129,836,339.61 | 129,833,112.35 | 129,529,194.72 | 120,430,918 |
| 预计负债 | 64,219,888.89 | 59,303,000 | 51,286,333.34 | 49,629,555.56 |
| 递延收益 | 59,387,019.29 | 60,414,441.22 | 63,231,763.15 | 60,351,959.82 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,081,759,865.6 | 1,053,120,691.54 | 693,067,575.35 | 682,262,526.03 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 6,503,378,769.92 | 6,454,294,970.81 | 6,498,399,773.4 | 6,534,818,771.77 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 661,279,045 | 661,279,045 | 661,279,045 | 661,279,045 |
| 资本公积 | 2,152,290,476.39 | 2,152,290,476.39 | 2,152,290,476.39 | 2,152,290,476.39 |
| 减:库存股 | 8,500,866.64 | 8,500,866.64 | 8,500,866.64 | 8,500,866.64 |
| 其他综合收益 | -7,963,418.88 | -7,897,948.33 | -9,575,626.65 | -5,192,924.8 |
| 盈余公积 | 105,373,822.86 | 105,373,822.86 | 105,373,822.86 | 105,373,822.86 |
| 未分配利润 | -646,189,411.75 | -566,109,801.7 | -495,579,610.22 | -500,116,501.35 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,256,289,646.98 | 2,336,434,727.58 | 2,405,287,240.74 | 2,405,133,051.46 |
| 少数股东权益 | 427,230,511.72 | 420,651,581.1 | 416,793,641.81 | 413,048,715.75 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,683,520,158.7 | 2,757,086,308.68 | 2,822,080,882.55 | 2,818,181,767.21 |
| 负债和股东权益合计 | 9,186,898,928.62 | 9,211,381,279.49 | 9,320,480,655.95 | 9,353,000,538.98 |
| 公告日期 | 2023-10-28 | 2023-08-29 | 2023-04-28 | 2023-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |